The letter of intent to acquire Lumar Diagnostic Imaging, Inc. represents another significant milestone in growing annual revenues. The transaction is based upon using cash and debt financing to complete the acquisition
Houston, Texas (PRWEB) January 23, 2008
Bederra Corporation (BDRR.pk) announces it has signed a letter of intent to acquire the assets receivables and liabilities of privately held Lumar Diagnostic Imaging, Inc.
Lumar Diagnostic Imaging, Inc., is a privately held Texas Corporation is located in Houston, Texas. Lumar Diagnostic Imaging, Inc. was formed to provide multi modality medical diagnostic imaging services such as MRI, CT, Ultrasound and Pain Management. The facility is located adjacent to the world-renowned Houston Texas Medical Center.
Graham Williams President of Bederra Corporation states, “The letter of intent to acquire Lumar Diagnostic Imaging, Inc. represents another significant milestone in growing annual revenues. The transaction is based upon using cash and debt financing to complete the acquisition”. Projected gross revenues from this acquisition for fiscal year 2008 are anticipated to be in excess of $ 3 million dollars with profits.
Lumar Diagnostic Imaging, Inc. will operate as a wholly owned subsidiary of Bederra Corporation when the acquisition is completed by the end of the first quarter 2008.
Bederra Corporation has 28,416,204 shares of common stock outstanding with 6 million shares in the public float as of January 22, 2008.
Safe Harbor Statement:
Statements contained in this release, which are not historical facts, may be considered "forward-looking statements" under the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on current expectations and the current economic environment. This press release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are subject to certain risks, trends and uncertainties that could cause actual results to differ materially from those projected.
281 540 0500